Drug Shortage Report for ENGERIX-B
| Report ID | 186642 |
| Drug Identification Number | 02487020 |
| Brand name | ENGERIX-B |
| Common or Proper name | Hepatitis B vaccine (recombinant) |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1s |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2023-03-06 |
| Estimated end date | 2023-05-01 |
| Actual end date | 2023-04-27 |
| Shortage status | Resolved |
| Updated date | 2023-04-28 |
| Company comments | Limited supply available for public programs. Supply unavailable for the private market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2023-03-10 | English | Compare |
| v2 | 2023-03-10 | French | Compare |
| v3 | 2023-03-24 | English | Compare |
| v4 | 2023-03-24 | French | Compare |
| v5 | 2023-04-28 | English | Compare |
| v6 | 2023-04-28 | French | Compare |
Showing 1 to 6 of 6